Ozempic Boom Is an Opportunity for Health Insurers
Demand for GLP-1 weight loss drugs could be a net positive for insurance companies with pharmacy-benefit businesses.Read More
Ozempic Boom Is an Opportunity for Health Insurers
Demand for GLP-1 weight loss drugs could be a net positive for insurance companies with pharmacy-benefit businesses.Read More
Ozempic Boom Is an Opportunity for Health Insurers
Demand for GLP-1 weight loss drugs could be a net positive for insurance companies with pharmacy-benefit businesses.Read More
A Small Country Far From Ukraine Is Sending Hundreds toWar, on Both Sides
Scores of young Nepali men have gone to fight, some lured by Russia’s promise of work, others to fight for Ukraine, raising the prospect of Nepalis fighting one another in a distant war.Read More
Crypto Influencers and ‘Degenerates’ Flock to Sam Bankman-Fried’s Trial
The presence of crypto YouTubers, podcasters and commentators at the FTX founder’s fraud trial has created something of a culture clash in the courtroom.Read More
Sam Bankman-Fried’s Trial Reveals New Details of How FTX Died
Prosecutors in the criminal fraud case have built the most intricate account to date of the cryptocurrency exchange’s frantic final days.Read More
Cities Foster Serendipity. But Can They Do It When Workers Are at Home?
Revisiting a theory about chance collisions and innovation.Read More
The Federal Deficit Is Growing. This Is Why.
Tax receipts dipped unexpectedly last year. The Biden administration blames Republican tax cuts, but the truth is more complicated.Read More
A Deal for Aid Into Gaza, and More
Plus, President Biden’s speech to Congress and how the Texas governor’s bus program has altered the immigration debate.Read More
On Israel, Progressive Jews Feel Abandoned by Their Left-Wing Allies
Jewish leaders and voters said they were taken aback to discover that many of their ideological allies saw them as oppressors who deserved blame following the Israel attacks.Read More
